Lodisure 1 mg tablets for cats
Lodisure 1 mg tablets for cats
Authorised
- Amlodipine besilate
Product identification
Medicine name:
Lodisure 1 mg tablets for cats
Lodisure 1 mg Tablet
Lodisure 1 mg Comprimé
Lodisure 1 mg Tablette
Active substance:
- Amlodipine besilate
Target species:
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Amlodipine besilate1.40/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
-
Cat
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QC08CA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Blister made of PVC /aluminium / OPA with a push-through PVC-PVDC/aluminium lidding foil. Each blister contains 14 tablets.1 cardboard carton with 168 tablets.
- Blister made of PVC /aluminium / OPA with a push-through PVC-PVDC/aluminium lidding foil. Each blister contains 14 tablets.1 cardboard carton with 28 tablets.
- Blister made of PVC /aluminium / OPA with a push-through PVC-PVDC/aluminium lidding foil. Each blister contains 14 tablets.1 cardboard carton with 84 tablets.
- Blister made of PVC /aluminium / OPA with a push-through PVC-PVDC/aluminium lidding foil. Each blister contains 14 tablets.1 cardboard carton with 56 tablets.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V579733
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0339/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 6/11/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
How useful was this page?: